Autopsy report · NCT00076635

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

“program discontinued based on GIPF-007 results”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 3 years 5 months before it stopped.
• 91 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

InterMune

Sponsor type

Industry

Conditions

Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Lung Disease

Interventions

Interferon gamma-1b

Participants

91

Sites

1

Countries

United States

Trials that died the same way

• A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
  “Study design changes were needed based on GIPF-001 results” (60% match in meaning)
• A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus
  “Program Development discontinued” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.